Fulcrum Therapeutics, Inc.·4

Jun 29, 4:16 PM ET

Oltmans Curtis Gale 4

4 · Fulcrum Therapeutics, Inc. · Filed Jun 29, 2021

Insider Transaction Report

Form 4
Period: 2021-06-28
Oltmans Curtis Gale
Chief Legal Officer
Transactions
  • Purchase

    Common Stock

    2021-06-28$9.01/sh+1,088$9,8031,088 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION